RN Barcia, MR Dana, A Kazlauskas - American Journal of Transplantation, 2007 - interscience.wiley.com Corneal transplants normally enjoy a high percentage of survival, mainly because
the eye is an immune-privileged site. When allograft failure occurs, it is most
commonly due to rejection, an immune-mediated reaction that targets the ... Cited by 17 - Related articles - BL Direct - All 3 versions
[CITATION] This approach to improving corneal allograft survival involves lentiviral delivery of Bcl-xl to …
RN Barcia, MR Dana, A Kazlauskas - American Journal of Transplantation, 2007 - Blackwell Publishing Ltd Related articles
T Funaki, N Ebihara, A Murakami, A Nakao - Japanese Journal of Ophthalmology, 2008 - Springer Corneal endothelial cells are inhibited in the G1 phase of the cell cycle in
vivo, but retain the ability to proliferate in vitro, 1–7 suggesting that
these cells are actively maintained in a nonproliferative state in vivo. ... Related articles - All 2 versions
T Hayashi, S Yamagami, K Tanaka, S Yokoo, … - Investigative Ophthalmology & Visual Science, 2009 - ARVO RESULTS. Chimeric CEC allografts composed of cultured allogeneic CECs did not
provoke rejection reaction, DTH, or mixed-lymphocyte reactions, unlike the high
rejection rate that occurred in full-thickness corneal allografts. Adoptive ... Related articles - All 3 versions